Nuclear receptor profile in calvarial bone cells undergoing osteogenic versus adipogenic differentiation

Journal of Cellular Biochemistry

Volumn 105, Issue 5, 2008, Pages 1316-1326

  Pirih, Flavia Q ^a   Abayahoudian, Rosette ^b   Elashoff, David ^b   Parhami, Farhad ^b   Nervina, Jeanne M ^b   Tetradis, Sotirios ^b  

^a UNIVERSITY OF MICHIGAN SCHOOL OF DENTISTRY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adipogenic; Differentiation; Nuclear receptors; Osteogenic

Indexed keywords

CELL NUCLEUS RECEPTOR; CHICKEN OVALBUMIN UPSTREAM PROMOTER TRANSCRIPTION FACTOR 1; CHICKEN OVALBUMIN UPSTREAM PROMOTER TRANSCRIPTION FACTOR 2; CHICKEN OVALBUMIN UPSTREAM PROMOTER TRANSCRIPTION FACTOR 3; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGEN RELATED RECEPTOR ALPHA; ESTROGEN RELATED RECEPTOR BETA; ESTROGEN RELATED RECEPTOR GAMMA; GLUCOCORTICOID RECEPTOR; HEPATOCYTE NUCLEAR FACTOR 4; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; HEPATOCYTE NUCLEAR FACTOR 4GAMMA; LIVER X RECEPTOR ALPHA; LIVER X RECEPTOR BETA; NUCLEAR RECEPTOR NUR77; NUCLEAR RECEPTOR RELATED FACTOR 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROGESTERONE RECEPTOR; RETINOIC ACID RECEPTOR ALPHA; RETINOIC ACID RECEPTOR BETA; RETINOIC ACID RECEPTOR GAMMA; RETINOID X RECEPTOR ALPHA; RETINOID X RECEPTOR BETA; RETINOID X RECEPTOR GAMMA; THYROID HORMONE RECEPTOR ALPHA; THYROID HORMONE RECEPTOR BETA; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR;

ADIPOGENESIS; AMPLICON; ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; CALVARIA; CELL DIFFERENTIATION; CELL FUNCTION; CONTROLLED STUDY; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADIPOCYTES; ADIPOGENESIS; ANIMALS; CELL DIFFERENTIATION; MICE; OSTEOBLASTS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA, MESSENGER; SKULL; UP-REGULATION;

EID: 57149105118     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21931     Document Type: Article

References (83)

1. Ahdjoudj S, Fromigue O, Marie PJ. 2004. Plasticity and regulation of human bone marrow stromal osteoprogenitor cells: Potential implication in the treatment of age-related bone loss. Histol Histopathol 19:151-157.
2. Anon. 2006. Special issue IUPHAR compendium of the pharmacology and classification of the nuclear receptor superfamily. Pharmacol Rev 58.
3. Aubin JE, Liu F, Malaval L, Gupta AK. 1995. Osteoblast and chondroblast differentiation. Bone 17:77S-83S.
4. Balint E, Lapointe D, Drissi H, van der Meijden C, Young DW, van Wijnen AJ, Stein JL, Stein GS, Lian JB. 2003. Phenotype discovery by gene expression profiling: Mapping of biological processes linked to BMP-2-mediated osteoblast differentiation. J Cell Biochem 89:401-426.
5. Barish GD, Downes M, Alaynick WA, Yu RT, Ocampo CB, Bookout AL, Mangelsdorf DJ, Evans RM. 2005. A nuclear receptor atlas: Macrophage activation. Mol Endocrinol 19:2466-2477.
6. Beavan S, Horner A, Bord S, Ireland D, Compston J. 2001. Colocalization of glucocorticoid and mineralocorticoid receptors in human bone. J Bone Miner Res 16:1496-1504.
7. Beck GR, Jr., Zerler B, Moran E. 2001. Gene array analysis of osteoblast differentiation. Cell Growth Differ 12:61-83.
8. Bellows CG, Heersche JN. 2001. The frequency of common progenitors for adipocytes and osteoblasts and of committed and restricted adipocyte and osteoblast progenitors in fetal rat calvaria cell populations. J Bone Miner Res 16:1983-1993.
9. Beresford JN, Bennett JH, Devlin C, Leboy PS, Owen ME. 1992. Evidence for an inverse relationship between the differentiation of adipocytic and osteogenic cells in rat marrow stromal cell cultures. J Cell Sci 102:341-351.
10. Billiard J, Moran RA, Whitley MZ, Chatterjee-Kishore M, Gillis K, Brown EL, Komm BS, Bodine PV. 2003. Transcriptional profiling of human osteoblast differentiation. J Cell Biochem 89:389-400.
11. Bookout AL, Jeong Y, Downes M, Yu RT, Evans RM, Mangelsdorf DJ. 2006. Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network. Cell 126:789-799.
12. Burkhardt R, Kettner G, Bohm W, Schmidmeier M, Schlag R, Frisch B, Mallmann B, Eisenmenger W, Gilg T. 1987. Changes in trabecular bone, hematopoiesis and bone marrow vessels in aplastic anemia, primary osteoporosis, and old age: A comparative histomorphometric study. Bone 8:157-164.
13. Caprio M, Feve B, Claes A, Viengchareun S, Lombes M, Zennaro MC. 2007. Pivotal role of the mineralocorticoid receptor in corticosteroid-induced adipogenesis. FASEB J 21:2185-2194.
14. Cariou B, van Harmelen K, Duran-Sandoval D, van Dijk TH, Grefhorst A, Abdelkarim M, Caron S, Torpier G, Fruchart JC, Gonzalez FJ, Kuipers F, Staels B. 2006. The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice. J Biol Chem 281:11039-11049.
15. Chawla A, Lazar MA. 1993. Induction of Rev-ErbA alpha, an orphan receptor encoded on the opposite strand of the alpha-thyroid hormone receptor gene, during adipocyte differentiation. J Biol Chem 268:16265-16269.
16. Cheng SL, Shao JS, Charlton-Kachigian N, Loewy AP, Towler DA. 2003. MSX2 promotes osteogenesis and suppresses adipogenic differentiation of multipotent mesenchymal progenitors. J Biol Chem 278:45969-45977.
17. Chomez P, Neveu I, Mansen A, Kiesler E, Larsson L, Vennstrom B, Arenas E. 2000. Increased cell death and delayed development in the cerebellum of mice lacking the rev-erbA(alpha) orphan receptor. Development 127:1489-1498.
18. Cummins CL, Mangelsdorf DJ. 2006. Liver X receptors and cholesterol homoeostasis: Spotlight on the adrenal gland. Biochem Soc Trans 34:1110-1113.
19. de Jong DS, Vaes BL, Dechering KJ, Feijen A, Hendriks JM, Wehrens R, Mummery CL, van Zoelen EJ, Olijve W, Steegenga WT. 2004. Identification of novel regulators associated with early-phase osteoblast differentiation. J Bone Miner Res 19:947-958.
20. Diascro DD, Jr., Vogel RL, Johnson TE, Witherup KM, Pitzenberger SM, Rutledge SJ, Prescott DJ, Rodan GA, Schmidt A. 1998. High fatty acid content in rabbit serum is responsible for the differentiation of osteoblasts into adipocyte-like cells. J Bone Miner Res 13:96-106.
21. Ducy P. 2000. Cbfa1: A molecular switch in osteoblast biology. Dev Dyn 219:461-471.
22. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G. 1997. Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation. Cell 89:747-754.
23. Eisen MB, Spellman PT, Brown PO, Botstein D. 1998. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 95:14863-14868.
24. Fu M, Sun T, Bookout AL, Downes M, Yu RT, Evans RM, Mangelsdorf DJ. 2005. A nuclear receptor atlas: 3T3-L1 adipogenesis. Mol Endocrinol 19:2437-2450.
25. Garcia T, Roman-Roman S, Jackson A, Theilhaber J, Connolly T, Spinella-Jaegle S, Kawai S, Courtois B, Bushnell S, Auberval M, Call K, Baron R. 2002. Behavior of osteoblast, adipocyte, and myoblast markers in genome-wide expression analysis of mouse calvaria primary osteoblasts in vitro. Bone 31:205-211.
26. Gimble JM, Zvonic S, Floyd ZE, Kassem M, Nuttall ME. 2006. Playing with bone and fat. J Cell Biochem 98:251-266.
27. Gregoire FM, Johnson PR, Greenwood MR. 1995. Comparison of the adipoconversion of preadipocytes derived from lean and obese Zucker rats in serum-free cultures. Int J Obes Relat Metab Disord 19:664-670.
28. Haydon RC, Zhou L, Feng T, Breyer B, Cheng H, Jiang W, Ishikawa A, Peabody T, Montag A, Simon MA, He TC. 2002. Nuclear receptor agonists as potential differentiation therapy agents for human osteosarcoma. Clin Cancer Res 8:1288-1294.
29. Hazra S, Xiong S, Wang J, Rippe RA, Krishna V, Chatterjee K, Tsukamoto H. 2004. Peroxisome proliferator-activated receptor gamma induces a phenotypic switch from activated to quiescent hepatic stellate cells. J Biol Chem 279:11392-11401.
30. Ibrahimi A, Sfeir Z, Magharaie H, Amri EZ, Grimaldi P, Abumrad NA. 1996. Expression of the CD36 homolog (FAT) in fibroblast cells: Effects on fatty acid transport. Proc Natl Acad Sci USA 93:2646-2651.
31. Ishida Y, Tertinegg I, Heersche JN. 1996. Progesterone and dexamethasone stimulate proliferation and differentiation of osteoprogenitors and progenitors for adipocytes and macrophages in cell populations derived from adult rat vertebrae. J Bone Miner Res 11:921-930.
32. Jackson ME. 1991. Negative regulation of eukaryotic transcription. J Cell Sci 100:1-7.
33. Jackson SM, Demer LL. 2000. Peroxisome proliferator-activated receptor activators modulate the osteoblastic maturation of MC3T3-E1 preosteoblasts. FEBS Lett 471:119-124.
34. Justesen J, Stenderup K, Ebbesen EN, Mosekilde L, Steiniche T, Kassem M. 2001. Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis. Biogerontology 2:165-171.
35. Justesen J, Pedersen SB, Stenderup K, Kassem M. 2004. Subcutaneous adipocytes can differentiate into bone-forming cells in vitro and in vivo. Tissue Eng 10:381-391.
36. Juvet LK, Andresen SM, Schuster GU, Dalen KT, Tobin KA, Hollung K, Haugen F, Jacinto S, Ulven SM, Bamberg K, Gustafsson JA, Nebb HI. 2003. On the role of liver X receptors in lipid accumulation in adipocytes. Mol Endocrinol 17:172-182.
37. Kalaany NY, Mangelsdorf DJ. 2006. LXRS and FXR: The yin and yang of cholesterol and fat metabolism. Annu Rev Physiol 68:159-191.
38. Kalajzic I, Kalajzic Z, Kaliterna M, Gronowicz G, Clark SH, Lichtler AC, Rowe D. 2002. Use of type I collagen green fluorescent protein transgenes to identify subpopulations of cells at different stages of the osteoblast lineage. J Bone Miner Res 17:15-25.
39. Kim SW, Her SJ, Kim SY, Shin CS. 2005. Ectopic overexpression of adipogenic transcription factors induces transdifferentiation of MC3T3-E1 osteoblasts. Biochem Biophys Res Commun 327:811-819.
40. Krezel W, Dupe V, Mark M, Dierich A, Kastner P, Chambon P. 1996. RXR gamma null mice are apparently normal and compound RXR alpha +/-/ RXR beta -/-/RXR gamma -/- mutant mice are viable. Proc Natl Acad Sci USA 93:9010-9014.
41. Lammi J, Huppunen J, Aarnisalo P. 2004. Regulation of the osteopontin gene by the orphan nuclear receptor Nurr1 in osteoblasts. Mol Endocrinol 18:1546-1547.
42. Lecka-Czernik B, Gubrij I, Moerman EJ, Kajkenova O, Lipschitz DA, Manolagas SC, Jilka RL. 1999. Inhibition of Osf2/Cbfa1 expression and terminal osteoblast differentiation by PPARgamma2. J Cell Biochem 74:357-371.
43. Lee SS, Pineau T, Drago J, Lee EJ, Owens JW, Kroetz DL, Fernandez-Salguero PM, Westphal H, Gonzalez FJ. 1995. Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol Cell Biol 15:3012-3022.
44. Lehrke M, Lazar MA. 2005. The many faces of PPARgamma. Cell 123:993-999.
45. Li XH, Zhang JC, Sui SF, Yang MS. 2005. Effect of daidzin, genistin, and glycitin on osteogenic and adipogenic differentiation of bone marrow stromal cells and adipocytic transdifferentiation of osteoblasts. Acta Pharmacol Sin 26:1081-1086.
46. Li M, Pan LC, Simmons HA, Li Y, Healy DR, Robinson BS, Ke HZ, Brown TA. 2006. Surface-specific effects of a PPARgamma agonist, darglitazone, on bone in mice. Bone 39:796-806.
47. Liu D, Zhang Z, Teng CT. 2005. Estrogen-related receptor-gamma and peroxisome proliferator-activated receptor-gamma coactivator-1alpha regulate estrogen-related receptor-alpha gene expression via a conserved multihormone response element. J Mol Endocrinol 34:473-487.
48. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402-408.
49. Lucarelli E, Sangiorgi L, Maini V, Lattanzi G, Marmiroli S, Reggiani M, Mordenti M, Alessandra Gobbi G, Scrimieri F, Zambon Bertoja A, Picci P. 2002. Troglitazione affects survival of human osteosarcoma cells. Int J Cancer 98:344-351.
50. Marie PJ, Kaabeche K. 2006. PPAR gamma activity and control of bone mass in skeletal unloading. PPAR Res 2006:1-6.
51. Maurin AC, Chavassieux PM, Meunier PJ. 2005. Expression of PPARgamma and beta/delta in human primary osteoblastic cells: Influence of polyunsaturated fatty acids. Calcif Tissue Int 76:385-392.
52. Metzger D, Imai T, Jiang M, Takukawa R, Desvergne B, Wahli W, Chambon P. 2005. Functional role of RXRs and PPARgamma in mature adipocytes. Prostaglandins Leukot Essent Fatty Acids 73:51-58.
53. Meunier P, Aaron J, Edouard C, Vignon G. 1971. Osteoporosis and the replacement of cell populations of the marrow by adipose tissue. A quantitative study of 84 iliac bone biopsies. Clin Orthop Relat Res 80:147-154.
54. Munroe SH, Lazar MA. 1991. Inhibition of c-erbA mRNA splicing by a naturally occurring antisense RNA. J Biol Chem 266:22083-22086.
55. Notini AJ, McManus JF, Moore A, Bouxsein M, Jimenez M, Chiu WS, Glatt V, Kream BE, Handelsman DJ, Morris HA, Zajac JD, Davey RA. 2007. Osteoblast deletion of exon 3 of the androgen receptor gene results in trabecular bone loss in adult male mice. J Bone Miner Res 22:347-356.
56. Nuttall ME, Gimble JM. 2000. Is there a therapeutic opportunity to either prevent or treat osteopenic disorders by inhibiting marrow adipogenesis? Bone 27:177-184.
57. Nuttall ME, Gimble JM. 2004. Controlling the balance between osteoblastogenesis and adipogenesis and the consequent therapeutic implications. Curr Opin Pharmacol 4:290-294.
58. Nuttall ME, Patton AJ, Olivera DL, Nadeau DP, Gowen M. 1998. Human trabecular bone cells are able to express both osteoblastic and adipocytic phenotype: Implications for osteopenic disorders. J Bone Miner Res 13:371-382.
59. Pei W, Bellows CG, Elsubeihi ES, Heersche JN. 2003. Effect of ovariectomy on dexamethasone- and progesterone-dependent osteoprogenitors in vertebral and femoral rat bone cell populations. Bone 33:822-830.
60. Pei W, Bellows CG, Jia Y, Heersche JN. 2006. Effect of age on progesterone receptor expression, and osteoprogenitor proliferation and differentiation in female rat vertebral cell populations. J Endocrinol 190:261-270.
61. Pirih FQ, Nervina JM, Pham L, Aghaloo T, Tetradis S. 2003. Parathyroid hormone induces the nuclear orphan receptor NOR-1 in osteoblasts. Biochem Biophys Res Commun 306:144-150.
62. Pirih FQ, Tang A, Ozkurt IC, Nervina JM, Tetradis S. 2004. Nuclear orphan receptor Nurr1 directly transactivates the osteocalcin gene in osteoblasts. J Biol Chem 279:53167-53174.
63. Pirih FQ, Aghaloo TL, Bezouglaia O, Nervina JM, Tetradis S. 2005. Parathyroid hormone induces the NR4A family of nuclear orphan receptors in vivo. Biochem Biophys Res Commun 332:494-503.
64. Rizzo G, Disante M, Mencarelli A, Renga B, Gioiello A, Pellicciari R, Fiorucci S. 2006. The farnesoid X receptor promotes adipocyte differentiation and regulates adipose cell function in vivo. Mol Pharmacol 70:1164-1173.
65. Robertson KM, Norgard M, Windahl SH, Hultenby K, Ohlsson C, Andersson G, Gustafsson JA. 2006. Cholesterol-sensing receptors, liver X receptor alpha and beta, have novel and distinct roles in osteoclast differentiation and activation. J Bone Miner Res 21:1276-1287.
66. Robinson-Rechavi M, Escriva Garcia H, Laudet V. 2003. The nuclear receptor superfamily. J Cell Sci 116:585-586.
67. Rosen CJ, Bouxsein ML. 2006. Mechanisms of disease: Is osteoporosis the obesity of bone? Nat Clin Pract Rheumatol 2:35-43.
68. Schoonjans K, Peinado-Onsurbe J, Lefebvre AM, Heyman RA, Briggs M, Deeb S, Staels B, Auwerx J. 1996. PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene. EMBO J 15:5336-5348.
69. Schroeder TM, Nair AK, Staggs R, Lamblin AF, Westendorf JJ. 2007. Gene profile analysis of osteoblast genes differentially regulated by histone deacetylase inhibitors. BMC Genomics 8:362.
70. Semple RK, Chatterjee VK, O'Rahilly S. 2006. PPAR gamma and human metabolic disease. J Clin Invest 116:581-589.
71. Sinal CJ, Tohkin M, Miyata M, Ward JM, Lambert G, Gonzalez FJ. 2000. Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell 102:731-744.
72. Singh R, Artaza JN, Taylor WE, Gonzalez-Cadavid NF, Bhasin S. 2003. Androgens stimulate myogenic differentiation and inhibit adipogenesis in C3H 10T1/2 pluripotent cells through an androgen receptor-mediated pathway. Endocrinology 144:5081-5088.
73. Singh NK, Chae HS, Hwang IH, Yoo YM, Ahn CN, Lee SH, Lee HJ, Park HJ, Chung HY. 2006. Transdifferentiation of porcine satellite cells to adipoblasts with ciglitizone. J Anim Sci 85:1126-1135.
74. Tetradis S, Bezouglaia O, Tsingotjidou A. 2001a. Parathyroid hormone induces expression of the nuclear orphan receptor Nurr1 in bone cells. Endocrinology 142:663-670.
75. Tetradis S, Bezouglaia O, Tsingotjidou A, Vila A. 2001b. Regulation of the nuclear orphan receptor Nur77 in bone by parathyroid hormone. Biochem Biophys Res Commun 281:913-916.
76. Tontonoz P, Hu E, Devine J, Beale EG, Spiegelman BM. 1995a. PPAR gamma 2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene. Mol Cell Biol 15:351-357.
77. Tontonoz P, Hu E, Spiegelman BM. 1995b. Regulation of adipocyte gene expression and differentiation by peroxisome proliferator activated receptor gamma. Curr Opin Genet Dev 5:571-576.
78. Ulven SM, Dalen KT, Gustafsson JA, Nebb HI. 2005. LXR is crucial in lipid metabolism. Prostaglandins Leukot Essent Fatty Acids 73:59-63.
79. Wang GJ, Sweet DE, Reger SI, Thompson RC. 1977. Fat-cell changes as a mechanism of avascular necrosis of the femoral head in cortisone-treated rabbits. J Bone Joint Surg Am 59:729-735.
80. Wu X, Peters JM, Gonzalez FJ, Prasad HS, Rohrer MD, Gimble JM. 2000. Frequency of stromal lineage colony forming units in bone marrow of peroxisome proliferator-activated receptor-alpha-null mice. Bone 26:21-26.
81. Yamanouchi K, Ban A, Shibata S, Hosoyama T, Murakami Y, Nishihara M. 2007. Both PPARgamma and C/EBPalpha are sufficient to induce transdifferentiation of goat fetal myoblasts into adipocytes. J Reprod Dev 53:563-572.
82. Yeh S, Tsai MY, Xu Q, Mu XM, Lardy H, Huang KE, Lin H, Yeh SD, Altuwaijri S, Zhou X, Xing L, Boyce BF, Hung MC, Zhang S, Gan L, Chang C. 2002. Generation and characterization of androgen receptor knockout (ARKO) mice: An in vivo model for the study of androgen functions in selective tissues. Proc Natl Acad Sci USA 99:13498-13503.
83. Zhang S, Uchida S, Inoue T, Chan M, Mockler E, Aubin JE. 2006. Side population (SP) cells isolated from fetal rat calvaria are enriched for bone, cartilage, adipose tissue and neural progenitors. Bone 38:662-670.